Up to 100 g of Intravenous Vitamin C Appears to be Safe and Elicits No Adverse Effects but Needs Further Evaluation in High-Risk Groups

MLA

Patrick M. Honore, et al. “Up to 100 g of Intravenous Vitamin C Appears to Be Safe and Elicits No Adverse Effects but Needs Further Evaluation in High-Risk Groups.” Clinical Pharmacokinetics, vol. 61, no. 9, June 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....87a57363b780913180753aa80973c609&authtype=sso&custid=ns315887.

APA

Patrick M. Honore, Sydney Blackman, Ibrahim Bousbiat, Emily Perriens, & Rachid Attou. (2022). Up to 100 g of Intravenous Vitamin C Appears to be Safe and Elicits No Adverse Effects but Needs Further Evaluation in High-Risk Groups. Clinical Pharmacokinetics, 61(9).

Chicago

Patrick M. Honore, Sydney Blackman, Ibrahim Bousbiat, Emily Perriens, and Rachid Attou. 2022. “Up to 100 g of Intravenous Vitamin C Appears to Be Safe and Elicits No Adverse Effects but Needs Further Evaluation in High-Risk Groups.” Clinical Pharmacokinetics 61 (9). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....87a57363b780913180753aa80973c609&authtype=sso&custid=ns315887.